The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3583-3586

  Tahara, Maino ^a   Ohno, Shinji ^b   Sakai, Kouji ^a   Ito, Yuri ^c   Fukuhara, Hideo ^c   Komase, Katsuhiro ^a   Brindley, Melinda A ^d   Rota, Paul A ^e   Plemper, Richard K ^d   Maenaka, Katsumi ^c   Takeda, Makoto ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CONSERVED NEUTRALIZING EPITOPE; EPITOPE; NECTIN 4; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ;

ARTICLE; BINDING SITE; CONTROLLED STUDY; MEASLES VIRUS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR BINDING SITE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; HEMAGGLUTININS, VIRAL; MEASLES VIRUS;

EID: 84874702063     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03029-12     Document Type: Article

References (26)

1. Tatsuo H, Ono N, Tanaka K, Yanagi Y. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897.
2. Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD. 2011. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 7:e1002240. doi:10.1371/journal.ppat .1002240.
3. M-hlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VH, Navaratnarajah CK, Frenzke M, Wong XX, Sawatsky B, Ramachandran S, McCray PB, Jr, Cichutek K, von Messling V, Lopez M, Cattaneo R. 2011. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480:530-533.
4. Takeda M, Tahara M, Nagata N, Seki F. 2011. Wild-type measles virus is intrinsically dual-tropic. Front. Microbiol. 2:279. doi:10.3389/fmicb.2011 .00279.
5. de Swart RL, Yuksel S, Osterhaus AD. 2005. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J. Virol. 79:11547-11551.
6. Bouche FB, Ertl OT, Muller CP. 2002. Neutralizing B cell response in measles. Viral Immunol. 15:451-471.
7. de Swart RL, Yuksel S, Langerijs CN, Muller CP, Osterhaus AD. 2009. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies. J. Gen. Virol. 90: 2982-2989.
8. Duke T, Mgone CS. 2003. Measles: not just another viral exanthem. Lancet 361:763-773.
9. Sanders R, Dabbagh A, Featherstone D. 2011. Risk analysis for measles reintroduction after global certification of eradication. J. Infect. Dis. 204(Suppl 1):S71-S77.
10. Bellini WJ, Rota PA. 2011. Biological feasibility of measles eradication. Virus Res. 162:72-79.
11. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K. 2007. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc. Natl. Acad. Sci. U. S. A. 104:19535-19540.
12. Tahara M, Ito Y, Brindley MA, Ma X, He J, Xu S, Fukuhara H, Sakai K, Komase K, Rota PA, Plemper RK, Maenaka K, Takeda M. 2013. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J. Virol. 87:666-675.
13. Sato TA, Fukuda A, Sugiura A. 1985. Characterization of major structural proteins of measles virus with monoclonal antibodies. J. Gen. Virol. 66(Pt 7):1397-1409.
14. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M. 2000. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74:6643-6647.
15. Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y. 2008. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 82: 4630-4637.
16. Leonard VH, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, Braun W, McCray PB, McChesney MB, Cattaneo R. 2008. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Invest. 118:2448-2458.
17. Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. 2004. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J. Virol. 78:302-313.
18. Zhang X, Lu G, Qi J, Li Y, He Y, Xu X, Shi J, Zhang C, Yan J, Gao GF. 2013. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat. Struct. Mol. Biol. 20:67-72.
19. Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K, Yanagi Y. 2011. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat. Struct. Mol. Biol. 18:135-141.
20. Shirogane Y, Takeda M, Tahara M, Ikegame S, Nakamura T, Yanagi Y. 2010. Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J. Biol. Chem. 285:20882-20890.
21. Takeda M, Ohno S, Tahara M, Takeuchi H, Shirogane Y, Ohmura H, Nakamura T, Yanagi Y. 2008. Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J. Virol. 82:11979-11984.
22. Hu A, Sheshberadaran H, Norrby E, Kovamees J. 1993. Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 192:351-354.
23. Hummel KB, Bellini WJ. 1995. Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J. Virol. 69:1913-1916.
24. Kato S, Ohgimoto S, Sharma LB, Kurazono S, Ayata M, Komase K, Takeda M, Takeuchi K, Ihara T, Ogura H. 2009. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM. Vaccine 27:3838-3848.
25. Sheshberadaran H, Norrby E. 1986. Characterization of epitopes on the measles virus hemagglutinin. Virology 152:58-65.
26. Ertl OT, Wenz DC, Bouche FB, Berbers GA, Muller CP. 2003. Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response. Arch. Virol. 148:2195-2206.